EW vs LION · P/E 47, rev $3.39B vs rev $2.63B
Edwards Lifesciences Corp (EW) versus Lionsgate Studios Holding Corp. (to be renamed Lionsgate Studios Corp.) (LION) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Lionsgate Studios Holding Corp. (to be renamed Lionsgate Studios Corp.) (LION) is a shell companies company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported LION revenue for 2026-03-31 was $2.63B. Net income was -$198.3M. Revenue was down 17.6% from 2025-03-31 to 2026-03-31. LION currently screens at market cap $1.67B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. LION currently screens at market cap $1.67B.
Not investment advice. Open the EW and LION stock pages for the full models.
Not investment advice.